‍What are the mechanism(s) that (largely) bypass the innate immune system upon vaccination with non-replicating vaccines (like mRNA)

The higher affinity is explained by the specificity of infection-enhancing Abs (IEAbs) for spike (innate Abs don’t have this level of specif

For those children who, unfortunately, have gotten a Covid-19 vaccine, does this one hijacking (the shot(s) and subsequent infections that a

Synopsis
The following predictions are distilled from an in-depth analysis of how the precipitated evolutionary dynamics of SARS-CoV-2 (SC-2) in highly vaccinated populations enable the virus to bypass the cell-based innate immune system (CBIIS) and exhaust…

VSS Scientific Updates During Pandemic Times #30 : 1.
WHO Declares Monkeypox Outbreak a Global Health Emergency

Weak immune activation by glycosylated ASLI- or ASLD-enabling viruses (that occurs, for example, during asymptomatic-mild natural infection)

Antibody-based vaccines teach the immune system to produce high levels of antibodies that are directed against the surface protein that is r

The following predictions are distilled from an in-depth analysis of how the precipitated evolutionary dynamics of SARS-CoV-2 (SC-2) in high

We, the undersigned health professionals and scientists, have huge concerns about the safety and necessity of Covid-19 vaccines for children

This is disgusting. As someone who has dedicated 3 decades of his professional life to analyzing the shortcomings of our traditional vaccin

Vaccination of vulnerable groups against monkeypox virus (MPV) in a highly C-19 vaccinated population will drive adaptive evolution of MPV a

VSS Scientific Updates During Pandemic Times #31 : Elevated Risk of Infection with SARS-CoV-2 Beta, Gamma, and Delta Variant Compared to

VSS Scientific Updates During Pandemic Times #32 : Is COVID Prematurely Aging our Immune Systems? “The concern is that people will be less a

MIS-C is a disease that may occur in school-age children two to six weeks after infection with SARS-CoV-2 (SC-2) virus. MIS-C is a post-infe

Bivalent mRNA booster candidates[1] have been developed as a next step in the development of C-19 vaccines to combat the virus; these new vaccines target the induction of a broader immune response than the original vaccines and have to some extent already…